PTX 2.27% 4.3¢ prescient therapeutics limited

They will be making a hell of a lot out of subsequent sales of...

  1. 7,702 Posts.
    lightbulb Created with Sketch. 3260
    They will be making a hell of a lot out of subsequent sales of equipment, instrumentation, software, training and servicing that derives from a successful outcome from our 12-mth collaborative R&D period. TFS will obviously financially benefit from their direct sales and sevices that incorporate OmnniCAR and PTX will derive royalties perhaps from TFS and licensing fees from each, lab, cancer centre and hospital for each and every manufacturing run. Obviously a supply chain system will be built into each machine for transaction purposes. Well, that's the way I envisage the monetary setup working. The multiplying effect (for both companies) could be enormous.

    PS: TFS is a mult billion dollar co who spend billions on R&D. Its not mates rates. And, yes, we own the licensing rights to OmniCAR. Its called collaboration for a reason.

    Last edited by Shellbell: 31/10/22
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.3¢
Change
-0.001(2.27%)
Mkt cap ! $34.62M
Open High Low Value Volume
4.3¢ 4.5¢ 4.3¢ $17.99K 416.9K

Buyers (Bids)

No. Vol. Price($)
6 152502 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 502504 5
View Market Depth
Last trade - 15.59pm 17/05/2024 (20 minute delay) ?
Last
4.3¢
  Change
-0.001 ( 4.44 %)
Open High Low Volume
4.3¢ 4.5¢ 4.3¢ 123400
Last updated 15.57pm 17/05/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.